Dior’s $230 ‘eau de senteur’ for infants recently went viral, touching off a fierce debate online about whether babies need a signature fragrance. But the idea of marketing perfume to the youngest customers is nothing new.
From Glossier-themed Bat Mitzvahs to the return of tramp stamps, the week in beauty news.
As strategics like Unilever and L’Oréal divest from once-core lines, a more selective approach to M&A is underway.
Welcome to Haul of Fame, a weekly roundup of the biggest beauty moments of the week, why they matter … and why some of them might not, even though they sure are gorgeous.
Facing an oversaturated beauty market, A-listers are returning to scents to profit off their image. Only now, you might find some of them stocked next to Byredo rather than at Walmart.
The beauty festival space flatlined when Covid-19 restricted large in-person events. This year, a number return, including Sephoria, which makes the case that the experiential event is back and better than ever.
Beauty brands are looking to neuroscent research and technology to sniff out the factors that lure buyers.
Long known for his music and fashion influence, the multi-hyphenate reflects on his expanding beauty business.
The line, which makes up more than half of the designer’s total business, is revving up its ambitions, with new retail partners and a new category launch: fragrance.
In August, the brand began teasing the launch of its three upcoming scents, Closeness, Rivulets and Bright, Hot, with peel-off fragrance strip samples in customers’ e-commerce orders. The scents, which will launch in October, were made in partnership with natural fragrance maker Robertet.
The London-based retailer known for its mock Tudor facade has big ambitions for the beauty category with its new LBTY label. First up: a line of high-end fragrances inspired by the retailer’s renowned prints.
Private equity shops and venture capitalists are being more discerning with their dollars and yet capital is still critical for emerging brands seeking to stand out in a competitive landscape.
DSM-Firmenich beat market expectations for second-quarter core earnings, said full-year sales growth should reach the upper end of its target range on the back of broad-based volume growth.